Term Description

This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Vedolizumab and anti-Vedolizumab test kits.

Part Descriptions

LP250843-2   Vedolizumab
Vedolizumab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD) including the subtypes Ulcerative colitis and Crohn's disease. IBD involves inflammation of the intestinal mucosa by leukocytes that cause a disruption in its barrier function. The leukocytes involved are T-cells that express α4β7 integrins which are the target for the drug vedolizumab. Vedolizumab prevents α4β7 integrin from binding with the endothelial surface and T-cells from penetrating the intestinal mucosa. Vedolizumab has proven to be a safe and effective treatment for IBD based in clinical research. Clinical studies have shown that vedolizumab helps achieve corticosteroid-free clinical remission. PMID: 27003961 Source: Regenstrief LOINC

LP250846-5   Vedolizumab Ab
In clinical trials, antibodies to vedolizumab (ATV) were present in about 4% of patients at any given time and were persistent in only 1% or less of patients receiving vedolizumab. https://www.healthcare.uiowa.edu/path_handbook/handbook/test3424.html In those patients with anti-vedolizumab antibodies, vedolizumab clearance was increased by about 12%, and for those with persistent antibodies, the trough concentration of vedolizumab was below detectable limits. Anti-drug antibodies can be one cause of treatment failure for vedolizumab as well as other monoclonal antibody therapeutics. PMID: 25996351 Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Vedolizumab Ab:MCnc:Pt:Ser/Plas:Qn:IA
Long Common Name
Vedolizumab Ab [Mass/volume] in Serum or Plasma by Immunoassay
Short Name
Vedolizumab Ab SerPl IA-mCnc
Display Name
Vedolizumab Ab IA [Mass/Vol]
Consumer Name Alpha Get Info
Vedolizumab antibody, Blood

Part Model Get Info

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.63
Last Updated
Version 2.73 (MIN)
Order vs. Observation
Both
Common Test Rank Get Info
6276

Member of these Panels

LOINCLong Common Name
90794-9Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Vedolizumab Ab:Hmotnostní koncentrace:Časový bod:Sérum/plazma:Kvantitativní:Imunoanalýza
el-GRGreek (Greece)Βεδολιζουμάμπη Αντίσωμα:MCnc:Pt:Ορός/Πλάσμα:Qn:IA
Synonyms: DRUG/TOX IA MCnc Pt Qn Αντίσωμα Βεδολιζουμάμπη Ορός Ορός/Πλάσμα Πλάσμα
es-ESSpanish (Spain)Vedolizumab Anticuerpos:Concentración de masa:Punto temporal:Suero o Plasma:Qn:IA
Synonyms: Cuantitativo
es-MXSpanish (Mexico)Vedolizumab Ab:Concentración de masa:Punto temporal:Suero o Plasma:Cuantitativo:Inmunoensayo
fr-FRFrench (France)Védolizumab Ac:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
it-ITItalian (Italy)Vedolizumab Ab:MCnc:Pt:Siero/Plasma:Qn:IA
Synonyms: anticorpo Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma
zh-CNChinese (China)维多珠单抗 抗体:质量浓度:时间点:血清/血浆:定量型:免疫测定法
Synonyms: Ab;自身抗体 免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 毒品 毒品类 水平;浓度;质量浓度(单位体积) 维多珠;Vedolizumab 单抗;维多株单抗;维多珠单克隆抗体 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类 血清或血浆

Example Units

UnitSource
ng/mLExample UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=86899-2